| 发明名称 |
Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists |
| 摘要 |
The invention relates to salts of (7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid which are useful for treating diseases affected by the activation of the IP receptor, pharmaceutical compositions that contain the salts and processes for preparing the salts are also described. |
| 申请公布号 |
US9174985(B2) |
申请公布日期 |
2015.11.03 |
| 申请号 |
US201314371593 |
申请日期 |
2013.01.11 |
| 申请人 |
Novartis AG |
发明人 |
Leblanc Catherine;McKeown Stephen Carl;Perlberg Anett;Tufilli Nicola |
| 分类号 |
C07D471/04 |
主分类号 |
C07D471/04 |
| 代理机构 |
|
代理人 |
Britt Shawn |
| 主权项 |
1. A crystalline form of the compound: |
| 地址 |
Basel CH |
